Evidence map›Paper›PMID 40980736›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2025

Dual-receptor PET imaging of ovarian cancer using a

Xiaodan Shi, Zhangxin Wu, Yifeng Yuan, Ying Wang, Shuo Yang, Rong Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaodan ShiState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.
Zhangxin WuState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.
Yifeng YuanState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.
Ying WangState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.
Shuo YangState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.
Rong LiState Key Laboratory of Female Fertility Promotion, National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction (Ministry of Education), Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiolabeled folate derivatives have been extensively investigated for positron emission tomography (PET) imaging of ovarian cancer due to the frequent overexpression of folate receptor α (FRα). However, clinical translation has been hindered, at least in part, by suboptimal tumor uptake of FRα-targeted radiotracers. In this study, we developed and characterized a

Indexed as

dual-targetingmolecular imagingOvarian cancerpositron emission tomographyradiopharmaceuticals

Identifiers

PMID40980736
PMCPMC12444400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.